-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Mereo BioPharma Group, Maintains $1 Price Target

Benzinga·11/10/2026 08:29:05
Listen to the news
BTIG analyst Julian Harrison reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Buy and maintains $1 price target.